Literature DB >> 1898971

Solid matrix-antibody-antigen complexes induce antigen-specific CD8+ cells that clear a persistent paramyxovirus infection.

R E Randall1, D F Young.   

Abstract

We have previously shown that the adoptive transfer of splenocytes, isolated from mice immunized by infection with the paramyxovirus simian virus 5 (SV5), enhance the speed of clearance of SV5 from the lungs of immunodeficient mice; clearance is mediated primarily through CD8+ effector cells and not by serum neutralizing antibody (D.F. Young, R.E. Randall, J.A. Hoyle, and B.E. Souberbielle, J. Virol. 64:5403-5411, 1990). In this article we demonstrate that immunization of mice with solid matrix-antibody-antigen (SMAA) complexes also induces CD8+ effector cells that are responsible for clearing persistent SV5 infections in immunodeficient mice. The demonstration that immunization with SMAA complexes (an exogenous antigen) can induce class I-restricted cytotoxic T lymphocytes (CTLs) suggests that that these cells may be responsible for virus clearance in vivo. This premise is supported indirectly by the observation that immunization with SMAA complexes was less efficient in inducing class I-restricted CTLs (as measured in vitro) than was infectious virus and that splenocytes isolated from mice immunized with SMAA complexes were also less efficient in clearing virus from lungs of immunodeficient mice than were splenocytes isolated from mice immunized by infection with virus. This was not because the SMAA complexes were generally less immunogenic than infectious virus, since mice immunized with SMAA complexes (which contained the HN protein of SV5) produced higher levels of neutralizing antibody than mice immunized with infectious virus. In the majority of experiments, fixed and killed suspensions of Staphylococcus aureus Cowan strain A were used as the solid matrix in the construction of SMAA complexes. However, in this article we present evidence that alum-antibody-antigen complexes are as immunogenic as S. aureus A-antibody-antigen complexes. These results suggest that the immunological reactivity of the solid matrix itself does not influence the intensity of the immune response to the antigens of interest in the SMAA complexes. The significance of these results for vaccine design are discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1898971      PMCID: PMC239811     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

Review 1.  MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Adv Immunol       Date:  1979       Impact factor: 3.543

2.  A virus-specific CD4+ cell-mediated cytolytic activity revealed by CD8+ cell elimination regularly develops in uncloned human antiviral cell lines.

Authors:  I Bourgault; A Gomez; E Gomard; F Picard; J P Levy; E Gomrad
Journal:  J Immunol       Date:  1989-01-01       Impact factor: 5.422

3.  Immunization against multiple viruses by using solid-matrix-antibody-antigen complexes.

Authors:  R E Randall; D F Young
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

4.  HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells.

Authors:  S Jacobson; R P Sekaly; C L Jacobson; H F McFarland; E O Long
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

5.  Isolation and characterization of monoclonal antibodies to simian virus 5 and their use in revealing antigenic differences between human, canine and simian isolates.

Authors:  R E Randall; D F Young; K K Goswami; W C Russell
Journal:  J Gen Virol       Date:  1987-11       Impact factor: 3.891

6.  Immunization with solid matrix-antibody-antigen complexes containing surface or internal virus structural proteins protects mice from infection with the paramyxovirus, simian virus 5.

Authors:  R E Randall; D F Young; J A Southern
Journal:  J Gen Virol       Date:  1988-10       Impact factor: 3.891

7.  T cell subpopulations required for the human cytotoxic T lymphocyte response to influenza virus: evidence for T cell help.

Authors:  W E Biddison; S O Sharrow; G M Shearer
Journal:  J Immunol       Date:  1981-08       Impact factor: 5.422

8.  Cells process exogenous proteins for recognition by cytotoxic T lymphocytes.

Authors:  J W Yewdell; J R Bennink; Y Hosaka
Journal:  Science       Date:  1988-02-05       Impact factor: 47.728

9.  Clearance of a persistent paramyxovirus infection is mediated by cellular immune responses but not by serum-neutralizing antibody.

Authors:  D F Young; R E Randall; J A Hoyle; B E Souberbielle
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

10.  Active immunization against virus infections due to antigenic drift by induction of crossreactive cytotoxic T lymphocytes.

Authors:  K Kuwano; M Scott; J F Young; F A Ennis
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

View more
  5 in total

1.  Variable domain sequences of mAb with high affinity for a linear oligopeptide.

Authors:  T Hanke; R E Randall
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

2.  Fine specificity of cellular immune responses in humans to human cytomegalovirus immediate-early 1 protein.

Authors:  N J Alp; T D Allport; J Van Zanten; B Rodgers; J G Sissons; L K Borysiewicz
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

3.  Measles virus transmembrane fusion protein synthesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I- and class II-restricted cytotoxic T cell recognition.

Authors:  R S van Binnendijk; C A van Baalen; M C Poelen; P de Vries; J Boes; V Cerundolo; A D Osterhaus; F G UytdeHaag
Journal:  J Exp Med       Date:  1992-07-01       Impact factor: 14.307

Review 4.  Converting monoclonal antibody-based immunotherapies from passive to active: bringing immune complexes into play.

Authors:  Jennifer Lambour; Mar Naranjo-Gomez; Marc Piechaczyk; Mireia Pelegrin
Journal:  Emerg Microbes Infect       Date:  2016-08-17       Impact factor: 7.163

5.  Virus growth and antibody responses following respiratory tract infection of ferrets and mice with WT and P/V mutants of the paramyxovirus Simian Virus 5.

Authors:  Gerald A Capraro; John B Johnson; Nancy D Kock; Griffith D Parks
Journal:  Virology       Date:  2008-05-05       Impact factor: 3.616

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.